CClinicalTrials.gg
CompletedNCT05441007HYPERCOUpdated Mar 11, 2026

The Effect of Hypercapnia on Physiological Parameters During Short-term Breathing

An interventional study of Hypoxic and Hypercapnic in Hypoxia, Hypercapnia and Cardiac Output, High, sponsored by Czech Technical University in Prague. Completed at 1 site in Czechia. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-11.

Sponsored by Czech Technical University in Prague · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The aim of the project is to evaluate the effect of hypercapnia on physiological parameters in a healthy person during short-term hypoxia and hypercapnia.

Read the detailed description

Hypercapnia causes changes in physiological parameters at various levels throughout the body. The study aims to evaluate the effect of hypercapnia on physiological parameters in a healthy person during short-term hypoxia and hypercapnia. It is an intervention prospective study that will be conducted at the Faculty of Biomedical Engineering on healthy volunteers. All the volunteers undergo three different phases in random order. The individual phases differ in the breathed mixture of oxygen, nitrogen and carbon dioxide gases. Non-invasive measurements of physiological parameters, especially blood oxygen saturation, perfusion index and cardiac output, will be performed continuously during the experiment.

02

Conditions studied

  • Hypoxia
  • Hypercapnia
  • Cardiac Output, High

Keywords

  • Cardiac Output
  • Perfusion index
  • Pulse oximetry
03

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy volunteers

Exclusion criteria

Exclusion Criteria:

  • pregnancy
  • severe cardiovascular conditions
  • severe asthma or other severe respiratory conditions
  • injury to the upper limbs or hands that could affect the peripheral perfusion
  • diabetes
  • hypotension or hypertension
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Hypoxic

    Participants inhale ambient air, the hypoxic gas mixture, and ambient air.

    Other: Hypoxic

  • Experimental
    Hypercapnic

    Participants inhale ambient air, the hypercapnic gas mixture, and ambient air.

    Other: Hypercapnic

  • Experimental
    Hypoxic and Hypercapnic

    Participants inhale ambient air, the hypoxic and hypercapnic gas mixture, and ambient air.

    Other: Hypoxic and Hypercapnic

Interventions

  • OtherHypoxic

    Hypoxic gas mixture Gas mixture of 10% O2 and 90% N2 for six minutes.

  • OtherHypercapnic

    Hypercapnic gas mixture Gas mixture of 21% O2, 5% CO2 74% N2 for six minutes.

  • OtherHypoxic and Hypercapnic

    Hypoxic and Hypercapnic gas mixture Gas mixture of 10% O2, 5% CO2 85% N2 for six minutes.

05

What researchers measure

Primary outcomes

  1. Changes in Cardiac output due to the induced hypoxia and hypercapnia

    Based on the induced hypoxia, hypercapnia or combination of hypoxia and hypercapnia, Cardiac output will change

    Time frame: 1 hour

  2. Changes in Perfusion index due to the induced hypoxia and hypercapnia

    Based on the induced hypoxia, hypercapnia or combination of hypoxia and hypercapnia, Perfusion index will change

    Time frame: 1 hour

06

Study locations

1 site
  • Czech Technical University in Prague
    Kladno, 27201, Czechia
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT05441007
Lead sponsor
Czech Technical University in Prague
Responsible party
Sponsor
First posted
Jul 1, 2022
Start date
Jun 22, 2022
Primary completion
Mar 30, 2024
Completion
Jun 30, 2024
Last update
Mar 11, 2026

Study contacts

Karel Roubik, Professor
principal investigator · Czech Technical University in Prague

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion